Filing Details

Accession Number:
0001209191-21-063969
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-10 19:04:50
Reporting Period:
2021-11-09
Accepted Time:
2021-11-10 19:04:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1865494 Io Biotech Inc. IOBT () G7
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1388325 A/S Holdings Novo Tuborg Havnevej 19
Hellerup G7 2900
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-09 2,952,932 $0.00 2,952,932 No 4 C Direct
Common Stock Acquisiton 2021-11-09 325,000 $14.00 3,277,932 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock SERIES B CONVERTIBLE PREFERRED STOCK Disposition 2021-11-09 217,107 $0.00 2,006,715 $0.00
Common Stock SERIES C CONVERTIBLE PREFERRED STOCK Disposition 2021-11-09 75,267 $0.00 946,217 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. The shares of preferred stock converted to common stock based on a conversion ratio that took into account interest that accrued since the date of issuance of the preferred stock and the price of the common stock sold to the underwriters in the IPO.
  2. Represents a purchase from the underwriters in the Issuer's initial public offering.